Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 2002

View Archived Issues

New data on the antioxidant capacity of phytochemicals

Daiichi updates status of quinolone antibacterial agents

Rights to angiotensin II receptor blocker for glaucoma licensed to Santen

Pioglitazone normalizes increased retinal leukocyte entrapment in diabetes

Cannabinoid agonist reduces IOP by decreasing aqueous humor flow

PKC-beta inhibition as an approach to the treatment of diabetic macular edema

Adenoviral gene transfer of PEDF inhibits choroidal neovascularization in animal models

CRF antagonists may be useful in the treatment of anxiety and affective disorders

Possible beneficial effects of GABA uptake inhibition on micturition

The health benefits of cranberries

Potent inhibitors of bacterial methionyl-tRNA synthetase active against Gram-positive pathogens

Immusol and Vertex collaborate on discovery of inflammation targets

Applied Molecular Evolution and Centocor sign antibody therapeutic optimization agreement

Design and SAR of new dual H1/H3 antagonists reported at ACS meeting

Kosan awarded SBIR grant for epothilone analogues

Ilex and Abgenix collaborate to develop antibody therapy for cancer

G-207 designated orphan drug in malignant glioma

Amgen acquires filgrastim and pegfilgrastim in Europe from Roche

IND approved for clinical trials of buccal morphine

FDA requests Provenge composition information from Dendreon

Dual CCR3 modulators/H1 antagonists designed at AstraZeneca

Roche patents new series of lanosterol synthase inhibitors

Trk tyrosine kinase inhibitors useful for cancer and pain according to GSK patent

Recent Chiron patent covers new pyridine and pyrimidine GSK3 inhibitors

New analgesics in the Gruenenthal pipeline

Uroselective alpha1-adrenoceptor blockers designed at Recordati

Inhibitors of cyclin-dependent kinases useful as antitumor agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...